News & Press Releases
Filter by:
Pratt's Privacy and Cybersecurity Report published an article by Privacy & Cybersecurity Practice Co-chair Scott Lashway, Special Counsel Matthew MK Stein, Of Counsel Cassandra Paolillo, and Associate Kayla LaRosa examining the differences between the New York legislature's version of Washington's My Health Data Act and the Washington law. The New York Health Information Privacy Act currently awaits Kathy Hochul’s signature.
Privacy & Cybersecurity Practice Co-chair Cynthia Larose published an article in Pratt's Privacy & Cybersecurity Law Report analyzing the California Privacy Protection Agency's first enforcement decision under the California Consumer Privacy Act following an investigation of American Honda Motor Co.
HHS Restructuring and Workforce Reductions
June 1, 2025
The Chicago Medicine Magazine recently published an article by Joanne Hawana, Lauren Moldawer, and Jeannie Mancheno, providing an overview of the Department of Health and Human Services’ restructuring and workforce reductions.
Patenting AI/ML Life Sciences and TechBio Innovations – How Much Disclosure Is Sufficient?
June 1, 2025
The Intellectual Property & Technology Law Journal published an article by Member Terri Shieh-Newton, PhD and Associate Hanna Kim about ensuring sufficient disclosure in patent applications for AI/machine learning and TechBio innovations in the life sciences sector.
States Become More Aggressive with PBM Reform
May 30, 2025
Managed Healthcare Executive featured insights from Mintz Member Theresa Carnegie, which stemmed from a recent webinar hosted by LucyRx, a fiduciary pharmacy benefit manager (PBM), about states’ efforts to regulate PBMs and their relationships with pharmacies in light of stalled federal reform. In the webinar, panelists discussed the impacts of states’ efforts to reform PBMs and their relationships with pharmacies.
The American Health Law Association published a briefing co-authored by Member Megan Preusker, which explores the unique considerations underlying the regulatory approval process in a distressed health care transaction, such as timing and liquidity constraints. The article also outlines strategies for how counterparties can navigate these complexities.
